detection technology
proposed diagnostic device
rapid diagnostic test
innovative detection device
picomolar detection
new biomarkers of infection
relevant biomarkers of infection
reference technology
novel biomarkers
quality of testing
Infection parameters
break
market
cross-sectional testing necessary
expected field conditions
mass testing campaigns
expected added value
malaria endemic areas
antibody response
therapeutic response
parasite species
parasite density
key advantage
multiple including
major competitive advantage
quantitative evaluations
ability
users
V-RDT
High sensitivity
tropical environments
eradication efforts
comprehensive nature
addition
information
prognosis
combination
minutes
approach
falciparum
simultaneous measures
Development
overall project objective
current tests
vivax
diagnoses
devices
shortcomings
ambition
Rapidity